Literature DB >> 28367398

Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis.

Stefan L Oliver1, Edward Yang1, Ann M Arvin1.   

Abstract

Varicella-zoster virus (VZV), an alphaherpesvirus that causes chicken pox (varicella) and shingles (herpes zoster), is a medically important pathogen that causes considerable morbidity and, on occasion, mortality in immunocompromised patients. Herpes zoster can afflict the elderly with a debilitating condition, postherpetic neuralgia, triggering severe, untreatable pain for months or years. The lipid envelope of VZV, similar to all herpesviruses, contains numerous glycoproteins required for replication and pathogenesis. PURPOSE OF REVIEW: To summarize the current knowledge about VZV glycoproteins and their roles in cell entry, replication and pathogenesis. RECENT
FINDINGS: The functions for some VZV glycoproteins are known, such as gB, gH and gL in membrane fusion, cell-cell fusion regulation, and receptor binding properties. However, the molecular mechanisms that trigger or mediate VZV glycoproteins remains poorly understood.
SUMMARY: VZV glycoproteins are central to successful replication but their modus operandi during replication and pathogenesis remain elusive requiring further mechanistic based studies.

Entities:  

Keywords:  Varicella zoster virus; fusion; glycoprotein; pathogenesis; receptor; replication

Year:  2016        PMID: 28367398      PMCID: PMC5373811          DOI: 10.1007/s40588-016-0044-4

Source DB:  PubMed          Journal:  Curr Clin Microbiol Rep        ISSN: 2196-5471


  96 in total

1.  Delayed biosynthesis of varicella-zoster virus glycoprotein C: upregulation by hexamethylene bisacetamide and retinoic acid treatment of infected cells.

Authors:  Johnathan Storlie; Wallen Jackson; Jennifer Hutchinson; Charles Grose
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 2.  Neurological disease produced by varicella zoster virus reactivation without rash.

Authors:  Don Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 3.  Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking.

Authors:  C Grose
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

4.  Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells.

Authors:  Martin I Muggeridge
Journal:  J Gen Virol       Date:  2000-08       Impact factor: 3.891

5.  Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus.

Authors:  T C Mettenleiter; L Zsak; F Zuckermann; N Sugg; H Kern; T Ben-Porat
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

6.  Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles.

Authors:  Johnathan Storlie; John E Carpenter; Wallen Jackson; Charles Grose
Journal:  Virology       Date:  2008-10-26       Impact factor: 3.616

7.  Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.

Authors:  Barbara Berarducci; Jaya Rajamani; Leigh Zerboni; Xibing Che; Marvin Sommer; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

8.  Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII).

Authors:  E A Montalvo; C Grose
Journal:  Virology       Date:  1986-03       Impact factor: 3.616

9.  Truncation of the carboxy-terminal 28 amino acids of glycoprotein B specified by herpes simplex virus type 1 mutant amb1511-7 causes extensive cell fusion.

Authors:  A Baghian; L Huang; S Newman; S Jayachandra; K G Kousoulas
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  αvβ6- and αvβ8-integrins serve as interchangeable receptors for HSV gH/gL to promote endocytosis and activation of membrane fusion.

Authors:  Tatiana Gianni; Stefano Salvioli; Liudmila S Chesnokova; Lindsey M Hutt-Fletcher; Gabriella Campadelli-Fiume
Journal:  PLoS Pathog       Date:  2013-12-19       Impact factor: 6.823

View more
  10 in total

1.  The C-terminus of varicella-zoster virus glycoprotein M contains trafficking motifs that mediate skin virulence in the SCID-human model of VZV pathogenesis.

Authors:  Leigh Zerboni; Phillip Sung; Marvin Sommer; Ann Arvin
Journal:  Virology       Date:  2018-08-14       Impact factor: 3.616

2.  Varicella-zoster virus: molecular controls of cell fusion-dependent pathogenesis.

Authors:  Stefan L Oliver; Momei Zhou; Ann M Arvin
Journal:  Biochem Soc Trans       Date:  2020-12-18       Impact factor: 5.407

3.  Construction and characterisation of glycoprotein E and glycoprotein I deficient mutants of Australian strains of infectious laryngotracheitis virus using traditional and CRISPR/Cas9-assisted homologous recombination techniques.

Authors:  Carol A Hartley; Joanne M Devlin; Marzieh Armat; Paola K Vaz; Glenn F Browning; Amir H Noormohammadi
Journal:  Virus Genes       Date:  2022-09-20       Impact factor: 2.198

4.  The Structures and Functions of VZV Glycoproteins.

Authors:  Stefan L Oliver
Journal:  Curr Top Microbiol Immunol       Date:  2021-11-04       Impact factor: 4.737

Review 5.  The structural basis of herpesvirus entry.

Authors:  Sarah A Connolly; Theodore S Jardetzky; Richard Longnecker
Journal:  Nat Rev Microbiol       Date:  2020-10-21       Impact factor: 60.633

6.  Identification and Visualization of Functionally Important Domains and Residues in Herpes Simplex Virus Glycoprotein K(gK) Using a Combination of Phylogenetics and Protein Modeling.

Authors:  Paul J F Rider; Lyndon M Coghill; Misagh Naderi; Jeremy M Brown; Michal Brylinski; Konstantin G Kousoulas
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

7.  Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.

Authors:  Su Jeen Lee; Hyo-Jung Park; Hae Li Ko; Jung Eun Lee; Hyun Joo Lee; Hun Kim; Jae-Hwan Nam
Journal:  Immun Inflamm Dis       Date:  2020-03-13

Review 8.  Targeting Host Cellular Factors as a Strategy of Therapeutic Intervention for Herpesvirus Infections.

Authors:  Kumari Asha; Neelam Sharma-Walia
Journal:  Front Cell Infect Microbiol       Date:  2021-03-19       Impact factor: 5.293

9.  Heparan sulfate 3-O-sulfotransferase 4 is genetically associated with herpes zoster and enhances varicella-zoster virus-mediated fusogenic activity.

Authors:  Seii Ohka; Souichi Yamada; Daisuke Nishizawa; Yoshiko Fukui; Hideko Arita; Kazuo Hanaoka; Masako Iseki; Jitsu Kato; Setsuro Ogawa; Ayako Hiranuma; Shinya Kasai; Junko Hasegawa; Masakazu Hayashida; Shuetsu Fukushi; Masayuki Saijo; And Kazutaka Ikeda
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

10.  Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella-Zoster Diagnosis.

Authors:  Arnaud John Kombe Kombe; Jiajia Xie; Ayesha Zahid; Huan Ma; Guangtao Xu; Yiyu Deng; Fleury Augustin Nsole Biteghe; Ahmed Mohammed; Zhao Dan; Yunru Yang; Chen Feng; Weihong Zeng; Ruixue Chang; Keyuan Zhu; Siping Zhang; Tengchuan Jin
Journal:  Pathogens       Date:  2022-01-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.